Nirmala Parajuli

6PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersTumour immunologyInnate immunityClinical pharmacology and therapeuticsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity.

Kalpana Subedi, Nirmal Parajuli, Xzaviar Kaymar Solone

|May 13, 2025
Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease.

Nirmal Parajuli, Kalpana Subedi, Xzaviar Kaymar Solone

|Aug 29, 2023
S14-Phosphorylated RPN6 Mediates Proteasome Activation by PKA and Alleviates Proteinopathy.

Liuqing Yang, Nirmal Parajuli, Penglong Wu

|Jul 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Michael Seimetz, Natascha Sommer, Mariola Bednorz

|Jul 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Michael Seimetz, Natascha Sommer, Mariola Bednorz

Pageof 1